Findings from the phase 3 randomized CABASTY clinical trial “may be practice changing,” investigators reported. Biweekly vs triweekly cabazitaxel for mCRPC in men aged 65 years or older has similar efficacy but is associated with a lower risk for neutropenia and/or neutropenic complications.
Cybersecurity experts weigh in on data breach impacting Oregonians kval.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kval.com Daily Mail and Mail on Sunday newspapers.
Cybersecurity experts weigh in on data breach impacting Oregonians kpic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kpic.com Daily Mail and Mail on Sunday newspapers.
Cybersecurity experts weigh in on data breach impacting Oregonians nbc16.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbc16.com Daily Mail and Mail on Sunday newspapers.